SE0401301D0 - Novel 3-triazolyl-galactoside inhibitors of galectins - Google Patents

Novel 3-triazolyl-galactoside inhibitors of galectins

Info

Publication number
SE0401301D0
SE0401301D0 SE0401301A SE0401301A SE0401301D0 SE 0401301 D0 SE0401301 D0 SE 0401301D0 SE 0401301 A SE0401301 A SE 0401301A SE 0401301 A SE0401301 A SE 0401301A SE 0401301 D0 SE0401301 D0 SE 0401301D0
Authority
SE
Sweden
Prior art keywords
novel
galectins
triazolyl
galectin
galactoside
Prior art date
Application number
SE0401301A
Other languages
English (en)
Swedish (sv)
Inventor
Ulf Nilsson
Hakon Leffler
Bader Abdalraheem Bade Salameh
Original Assignee
Forskarpatent I Syd Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forskarpatent I Syd Ab filed Critical Forskarpatent I Syd Ab
Priority to SE0401301A priority Critical patent/SE0401301D0/xx
Publication of SE0401301D0 publication Critical patent/SE0401301D0/xx
Priority to ES05741932.7T priority patent/ES2512501T3/es
Priority to EP05741932.7A priority patent/EP1751172B1/fr
Priority to CA2567700A priority patent/CA2567700C/fr
Priority to EP14174953.1A priority patent/EP2805961A1/fr
Priority to PCT/SE2005/000766 priority patent/WO2005113569A1/fr
Priority to CA2826538A priority patent/CA2826538A1/fr
Priority to US11/561,465 priority patent/US7700763B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0401301A 2004-05-21 2004-05-21 Novel 3-triazolyl-galactoside inhibitors of galectins SE0401301D0 (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE0401301A SE0401301D0 (sv) 2004-05-21 2004-05-21 Novel 3-triazolyl-galactoside inhibitors of galectins
ES05741932.7T ES2512501T3 (es) 2004-05-21 2005-05-23 Nuevos inhibidores de galectinas a base de 3-triazolil-galactósido
EP05741932.7A EP1751172B1 (fr) 2004-05-21 2005-05-23 Nouveaux inhibiteurs de galectines contenant 3-triazolyl-galactoside
CA2567700A CA2567700C (fr) 2004-05-21 2005-05-23 Inhibiteurs de galectines contenant 3-triazolyl-galactoside
EP14174953.1A EP2805961A1 (fr) 2004-05-21 2005-05-23 Nouveaux inhibiteurs 3-triazolyl-galactoside de galectines
PCT/SE2005/000766 WO2005113569A1 (fr) 2004-05-21 2005-05-23 Nouveaux inhibiteurs de galectines contenant 3-triazolyl-galactoside
CA2826538A CA2826538A1 (fr) 2004-05-21 2005-05-23 Inhibiteurs de galectines contenant 3-triazolyl-galactoside
US11/561,465 US7700763B2 (en) 2004-05-21 2006-11-20 3-triazolyl-galactoside inhibitors of galectins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0401301A SE0401301D0 (sv) 2004-05-21 2004-05-21 Novel 3-triazolyl-galactoside inhibitors of galectins

Publications (1)

Publication Number Publication Date
SE0401301D0 true SE0401301D0 (sv) 2004-05-21

Family

ID=32589764

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0401301A SE0401301D0 (sv) 2004-05-21 2004-05-21 Novel 3-triazolyl-galactoside inhibitors of galectins

Country Status (6)

Country Link
US (1) US7700763B2 (fr)
EP (2) EP2805961A1 (fr)
CA (2) CA2567700C (fr)
ES (1) ES2512501T3 (fr)
SE (1) SE0401301D0 (fr)
WO (1) WO2005113569A1 (fr)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5289757B2 (ja) * 2007-12-13 2013-09-11 ルネサスエレクトロニクス株式会社 液晶表示装置、データ駆動ｉｃ、及び液晶表示パネル駆動方法
US8697862B2 (en) 2008-05-16 2014-04-15 Galecto Biotech Ab Synthesis of galactoside inhibitors
ES2652488T3 (es) * 2009-04-28 2018-02-02 Galecto Biotech Ab Nuevos inhibidores de galactósidos de galectinas
US9243021B2 (en) 2012-10-31 2016-01-26 Galecto Biotech Ab Galactoside inhibitor of galectins
CN102276673B (zh) * 2011-06-21 2014-12-24 中国科学院成都生物研究所 一种2-脱氧-β-D-吡喃葡萄糖基三唑类化合物的制备方法
EP2620443A1 (fr) 2012-01-25 2013-07-31 Galecto Biotech AB Nouveaux inhibiteurs de galectines au galactoside
FR2990208A1 (fr) * 2012-05-07 2013-11-08 Centre Nat Rech Scient Derives de nucleosides, produits et compositions les comprenant, leurs utilisations therapeutiques et leurs procedes de synthese
JP6415437B2 (ja) 2012-09-17 2018-10-31 ガレクティン・セラピューティクス・インコーポレイテッドＧａｌｅｃｔｉｎ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． 癌の処置における特異的免疫療法を向上する方法
KR102231732B1 (ko) 2012-10-10 2021-03-23 갈렉틴 테라퓨틱스, 인크. 당뇨병성 신장병증 및 관련 질환의 치료를 위한 갈락토스 갈래의 탄수화물 화합물
IN2015DN02573A (fr) 2012-10-31 2015-09-11 Galecto Biotech Ab
EP2919802A4 (fr) * 2012-11-15 2016-09-14 Univ Tufts Méthodes, compositions et kits de traitement, de modulation ou de prévention de l'angiogenèse ou de la fibrose oculaire chez un sujet utilisant un inhibiteur de galectine
JP2016507503A (ja) 2012-12-20 2016-03-10 ヘンリー フォード ヘルス システム ガレクチン−３を阻害することによる拡張期心不全を治療する方法
US12390486B2 (en) 2012-12-20 2025-08-19 Henry Ford Health System Method for treating diastolic heart failure by inhibiting galectin-3
JP6735680B2 (ja) * 2014-07-09 2020-08-05 ガレクト バイオテック エービー ガレクチンの新規ハイブリッドガラクトシド阻害剤
CN104530163B (zh) * 2014-12-08 2017-08-22 华东理工大学 三氮唑糖脂类衍生物及其协同抗耐药菌的用途
WO2016113335A1 (fr) 2015-01-16 2016-07-21 Galecto Biotech Ab Nouvel inhibiteur galactoside de galectines
CA2970062C (fr) * 2015-01-30 2023-02-28 Galecto Biotech Ab Inhibiteurs alpha-d-galactoside de galectines
CN104817605B (zh) * 2015-04-14 2017-09-08 湖北工程学院 2‑（1’,2’,3’‑三氮唑‑4’‑氧苄基）‑1,3,4,6‑o‑乙酰基‑d‑葡萄糖及其制备方法和应用
CN104945456B (zh) * 2015-06-04 2018-01-05 湖北工程学院 2‑（1’,2’,3’‑三氮唑‑4’‑氧亚甲基吡啶）‑1,3,4,6‑o‑乙酰基‑d‑葡萄糖及其制备方法和应用
CN104945457B (zh) * 2015-06-10 2018-03-23 湖北工程学院 1‑（1’,3’,4’,6’–四‑O‑ 乙酰基‑α/β‑D‑葡萄吡喃糖）‑4‑对位取代芳基‑[1, 2, 3]‑三唑及其制备方法和应用
CA3000924A1 (fr) * 2015-11-09 2017-05-18 Galecto Biotech Ab Nouveaux inhibiteurs galactosides de galectines
US20190367552A1 (en) * 2016-03-04 2019-12-05 Galectin Sciences, Llc Selenogalactoside compounds for the prevention and treatment of diseases associated with galectin and the use thereof
CN109563120B (zh) * 2016-07-12 2022-12-02 格莱克特生物技术公司 半乳糖凝集素的α-D-半乳糖苷抑制剂
CN109563119A (zh) * 2016-07-12 2019-04-02 格莱克特生物技术公司 半乳糖凝集素的α-D-半乳糖苷抑制剂
KR102626669B1 (ko) * 2017-05-12 2024-01-17 갈랙틴 사이언시즈, 엘엘씨 질환의 예방 및 치료를 위한 화합물 및 이의 용도
CA3062649A1 (fr) * 2017-05-12 2018-11-15 Galectin Sciences, Llc Composes pour le traitement de troubles de la resistance systemique a l'insuline et leur utilisation
US11267811B2 (en) 2017-09-27 2022-03-08 Bristol-Myers Squibb Company Small molecule inhibitors of galectin-3
WO2019075045A1 (fr) 2017-10-11 2019-04-18 Bristol-Myers Squibb Company Inhibiteurs à petites molécules de galectine-3
US11548908B2 (en) 2017-12-29 2023-01-10 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3
CN111699193A (zh) 2018-01-10 2020-09-22 格莱克特生物技术公司 新型半乳糖苷类半乳凝素抑制剂
EP3807290B1 (fr) 2018-06-15 2022-03-30 Bristol-Myers Squibb Company Mimétiques de thiodisaccharides à base de tétrahydropyrane en tant qu'inhibiteurs de galectine-3
CA3102155A1 (fr) 2018-06-29 2020-01-02 Glykos Biomedical Oy Conjugues
CN113366007A (zh) 2018-10-15 2021-09-07 格莱克特生物技术公司 半乳糖凝集素的半乳糖苷抑制剂
CN113286632A (zh) 2018-10-15 2021-08-20 格莱克特生物技术公司 半乳糖凝集素的半乳糖苷抑制剂前药
US11447517B2 (en) 2018-11-21 2022-09-20 Galecto Biotech Ab Galactoside inhibitor of galectins
WO2020117883A1 (fr) 2018-12-06 2020-06-11 Bristol-Myers Squibb Company Inhibiteurs à petites molécules de la galectine-3
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3
JP7547345B2 (ja) 2018-12-27 2024-09-09 グリコミメティクス， インコーポレイテッド ガレクチン－３阻害性ｃ－グリコシド
EP3947407B1 (fr) 2019-03-26 2024-06-12 Bristol-Myers Squibb Company Inhibiteurs molecules petites de la galectin-3
US12269819B2 (en) 2019-04-10 2025-04-08 Bristol-Myers Squibb Company Small molecule inhibitors of Galectin-3
EP3983423A4 (fr) 2019-06-14 2023-07-19 Université Laval Synthèse de 3-azido-3-désoxy-d-galactopyranose
JP2022537737A (ja) * 2019-06-24 2022-08-29 ガレクト バイオテック エービー ３，３’－ジデオキシ－３，３’－ビス－［４－（３－フルオロフェニル）－１ｈ－１，２，３－トリアゾル－１－イル］－１，１’－スルファンジイル－ジ－ベータ－ｄ－ガラクトピラノシドの大規模方法
JP7674276B2 (ja) * 2019-07-03 2025-05-09 ガレクト バイオテック エービー ガレクチンの新規なガラクトシド阻害剤
WO2021001538A1 (fr) 2019-07-03 2021-01-07 Galecto Biotech Ab Nouvel inhibiteur de galectines du type galactoside
CA3143078A1 (fr) 2019-07-05 2021-01-14 Galecto Biotech Ab Nouvel inhibiteur galactoside de galectines
US12404295B2 (en) 2019-08-09 2025-09-02 Idorsia Pharmaceuticals Ltd (Hetero)aryl-methyl-thio-beta-D-galactopyranoside derivatives
KR102863667B1 (ko) 2019-08-09 2025-09-23 이도르시아 파마슈티컬스 리미티드 (2-아세트아미딜)티오-베타-d-갈락토피라노시드 유도체
MA56883B1 (fr) 2019-08-15 2025-04-30 Idorsia Pharmaceuticals Ltd Dérivés de 2-hydroxycycloalcane-1-carbamoyle
CN114585619B (zh) 2019-08-29 2024-09-27 爱杜西亚药品有限公司 α-D-吡喃半乳糖苷衍生物
US20230038373A1 (en) 2019-12-18 2023-02-09 Glykos Biomedical Oy Stabile conjugate
US12275720B2 (en) 2020-05-05 2025-04-15 Bristol-Myers Squibb Company Small molecule inhibitors of galectin-3
WO2021231243A1 (fr) 2020-05-11 2021-11-18 Bristol-Myers Squibb Company Inhibiteurs à petites molécules de galectine-3
CN115768768A (zh) 2020-05-28 2023-03-07 百时美施贵宝公司 半乳凝素-3抑制剂
WO2022073969A1 (fr) 2020-10-06 2022-04-14 Idorsia Pharmaceuticals Ltd Dérivés spiro d'alpha-d-galactopyranosides
US12291520B2 (en) 2020-11-02 2025-05-06 Idorsia Pharmaceuticals Ltd Galectin-3 inhibiting 2-hydroxycycloalkane-1-carbamoyl derivatives
JP7844491B2 (ja) 2021-02-09 2026-04-13 イドルシア・ファーマシューティカルズ・リミテッド ヒドロキシヘテロシクロアルカン－カルバモイル誘導体
WO2022184755A1 (fr) 2021-03-03 2022-09-09 Idorsia Pharmaceuticals Ltd Dérivés d'alpha-d-galactopyranoside substitués par triazolyl-méthyle

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05247078A (ja) * 1992-03-03 1993-09-24 Japan Tobacco Inc 糖化合物、シアル酸含有糖鎖類生合成阻害剤、その製造方法、並びに新規な中間体
AU5065399A (en) * 1998-08-06 2000-02-28 Teijin Limited Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix
US20060148712A1 (en) * 2000-03-13 2006-07-06 Fu-Tong Liu Monocyte chemoattractant activity of galectin-3
US7186681B2 (en) * 2000-03-13 2007-03-06 La Jolla Institute For Allergy And Immunology Methods of modulating cell migration using galectin-3
SE0100172D0 (sv) * 2001-01-22 2001-01-22 Ulf Nilsson New inhibitors against galectins

Also Published As

Publication number Publication date
CA2567700C (fr) 2013-10-15
EP1751172B1 (fr) 2014-07-09
ES2512501T3 (es) 2014-10-24
CA2567700A1 (fr) 2005-12-01
EP2805961A1 (fr) 2014-11-26
EP1751172A1 (fr) 2007-02-14
CA2826538A1 (fr) 2005-12-01
US7700763B2 (en) 2010-04-20
US20070185041A1 (en) 2007-08-09
WO2005113569A1 (fr) 2005-12-01

Similar Documents

Publication Publication Date Title
SE0401300D0 (sv) Novel Galactoside Inhibitors of Galectins
SE0100172D0 (sv) New inhibitors against galectins
ATE530524T1 (de) Substituierte sulfonamid-derivate
EA201101475A1 (ru) Способы применения рецептора gpr119 для идентификации соединений, которые можно использовать для увеличения костной массы субъекта
DK1853602T3 (da) Kemiske forbindelser
CY1108275T1 (el) Χημικες ενωσεις
MY149316A (en) Sirtuin modulating imidazohiazole compounds
TW200738688A (en) Compounds for the treatment of inflammatory disorders
EA201070328A1 (ru) Соединения триазолопиридина и их применение в качестве ингибиторов ask
WO2007084841A3 (fr) 1h-indoles substitues par un groupe sulfonyle en tant que ligands pour les recepteurs de la 5-hydroxytryptamine
NO20092652L (no) Konstruert anti-TSLP-antistoff
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
EP2344475A4 (fr) Quinazolinone, quinolone et analogues apparentés en tant que modulateurs de sirtuine
UA104447C2 (uk) Тіазолопіридинові сполуки, що модулюють сиртуїн
ATE482210T1 (de) Oxadiazolderivate als s1p1-rezeptor-agonisten
MX2010004965A (es) Derivados de amida como moduladores de la sirtuina.
EP1996612A4 (fr) Compositions destinee au traitement des cancers
EA201070327A1 (ru) Катехоламиновые производные и их пролекарства
EA201100605A1 (ru) Комбинированная терапия, включающая ингибитор dhodh и метотрексат, для лечения аутоиммунного заболевания
BRPI0914454A2 (pt) "composição para o tratamento do tecido epitelial"
EA200900261A1 (ru) Применение эсцина
DE602007011434D1 (de) 1h-indol-5-ylpiperazin-1-ylmethanonderivate
EA200700400A1 (ru) Производные n-(1h-индолил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии
ATE474574T1 (de) Imidazoazephinonverbindungen
NO20091771L (no) Ny krystall av (S)-(+)-2-(2-klorfenyl)-2-hydroksyetylkarbamat